Rigel Pharmaceuticals Inc (RIGL)

Operating Expenses

$165.90M

TTM · Period ending: · USD

RIGL logo

RIGL Operating Expenses

Latest reported$165.90M
RIGL Operating Expenses ($22.97M → $165.90M)
High-resolution chart · PNG

RIGL operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Rigel Pharmaceuticals Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
149,195,000
136,439,000
130,263,000
174,043,000
160,649,000
136,699,000
127,473,000
116,905,000
84,100,000
90,124,000
80,638,000
99,499,000
96,619,000
101,627,000
91,118,000
89,683,000
111,646,000
135,289,000
92,127,000
76,520,000
63,298,000
61,600,000
51,882,000
52,804,000
40,263,000
46,280,000
22,970,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.